Quantitative analysis for Cardiol Therapeutics Inc. (CRDL) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). 28 signals analyzed (23 differentiated alt-data).
CRDL stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $1.37 | $1.28 | $1.31 |
| 2026-05-11 | $1.39 | $1.32 | $1.34 |
| 2026-05-21 | $1.33 | $1.28 | $1.31 |
| 2026-06-03 | $1.15 | $1.10 | $1.12 |
| 2026-06-15 | $1.08 | $1.03 | $1.05 |
| 2026-06-26 | $1.06 | $1.00 | $1.04 |
| 2026-07-09 | $1.02 | $0.99 | $0.99 |
| 2026-07-21 | $1.30 | $1.22 | $1.24 |
| 2026-07-31 | $1.29 | $1.20 | $1.27 |
| 2026-08-12 | $1.52 | $1.43 | $1.52 |
| 2026-08-24 | $1.88 | $1.76 | $1.86 |
| 2026-09-03 | $2.20 | $2.09 | $2.16 |
How Cardiol Therapeutics Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc. | $146M | — |
| IVVD | Invivyd, Inc. | $145M | — |
| VXRT | Vaxart, Inc. | $148M | — |
| ABOS | Acumen Pharmaceuticals, Inc. | $142M | — |
View all Health Care stocks by valuation and signals →
Cardiol Therapeutics Inc. (CRDL) scores Unrated (50.0), with every measured dimension at or below 57. The weakest are analyst consensus at 28, across 2 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 57 |
| analyst consensus | 28 |
StoQuant analyzes 28 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Cardiol Therapeutics Inc. (CRDL): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/CRDL"><img src="https://stoquant.com/badge/CRDL.svg" alt="Cardiol Therapeutics Inc. (CRDL) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.